NUROSENE ANNOUNCES APPOINTMENT OF NEW CFO

TORONTO, July 18, 2022 /CNW/ – Nurosene Well being Inc. (“Nurosene” or the “Firm”) (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech firm targeted on delivering modern AI-based know-how options for psychological efficiency and wellness, appoints seasoned monetary government Swapan Kakumanu as Chief Monetary Officer.

“We’re excited to welcome Swapan to our senior government group. This appointment continues to show our dedication to constructing a world class administration group. Swapan is a confirmed CFO with a terrific monitor report of delivering ends in the capital market house. He shall be a terrific addition to the Nurosene group and we look ahead to the worth that his abilities can deliver to the corporate.” – CEO of Nurosene, George Achilleos.

Mr. Kakumanu brings over 25 years of senior finance and operations expertise. He has served at senior government administration ranges, each in private and non-private firms in excessive progress know-how, blockchain, manufacturing, buying and selling and oil subject providers industries. He has held senior administration roles as President, Chief Govt Officer and Chief Monetary Officer the place he has performed a key function in elevating over $200 million via numerous financing autos, together with debt, convertible debt, fairness and different non-dilutive devices each within the non-public and public markets. Mr. Kakumanu brings intensive expertise in public firm reporting, investor relations, mergers and acquisitions, inside controls and normal general monetary and operational administration.

About Nurosene

Nurosene is an AI healthtech firm targeted on addressing each acute and non-acute brain-centric situations. We now have developed an ecosystem of modern merchandise that immediately help brain-related situations. Our world-renowned group and companions are disrupting conventional psychological wellness remedies and are positioned on the forefront of vital analysis and improvements.  NetraMark, a completely owned subsidiary of Nurosene Well being Inc., is offering proprietary next-generation AI options for pharmaceutical and biotechnology firms throughout the spectrum of illness.

For extra info, go to www.nurosene.com.

Ahead-Wanting Statements

This press launch incorporates “forward-looking info” throughout the which means of relevant Canadian securities laws which relies upon Nurosene’s present inside expectations, estimates, projections, assumptions and beliefs, and views of future occasions. Ahead-looking info may be recognized by means of forward-looking terminology similar to “anticipate”, “probably”, “could”, “will”, “ought to”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and different comparable phrases, together with destructive and grammatical variations thereof, or statements that sure occasions or situations “could”, “would” or “will” occur, or by discussions of technique. Ahead-looking info consists of estimates, plans, expectations, opinions, forecasts, projections, targets, steering, or different statements that aren’t statements of truth.

Any forward-looking info speaks solely as of the date on which it’s made, and, besides as required by legislation, Nurosene doesn’t undertake any obligation to replace or revise any forward-looking info, whether or not because of new info, future occasions, or in any other case. New components emerge sometimes, and it isn’t attainable for Nurosene to foretell all such components. When contemplating these forward-looking statements, readers ought to be mindful the chance components and different cautionary statements in Nurosene’s Last Lengthy Type Prospectus dated Might 20, 2021 and Administration’s Dialogue and Evaluation for the yr ended September 30, 2021 (“MD&A”), and filed with the relevant Canadian securities regulatory authorities on SEDAR at www.sedar.com. The chance components and different components famous in Nurosene’s Last Lengthy Type Prospectus and MD&A may trigger precise occasions or outcomes to vary materially from these described in any forward-looking info.

 The CSE doesn’t settle for accountability for the adequacy or accuracy of this launch.

SOURCE Nurosene Well being Inc.

For additional info: Jaime Hackett, VP of Advertising, [email protected], 647.223.7165